{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:14:43Z","timestamp":1790277283594,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.contraception.2006.04.005","type":"journal-article","created":{"date-parts":[[2006,7,26]],"date-time":"2006-07-26T03:41:19Z","timestamp":1153885279000},"page":"293-296","source":"Crossref","is-referenced-by-count":57,"title":["Effects of transdermal and oral contraceptives on estrogen-sensitive hepatic proteins"],"prefix":"10.1016","volume":"74","author":[{"given":"Terry","family":"White","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beg\u00fcm","family":"\u00d6zel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank Z.","family":"Stanczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2006.04.005_bib1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0010-7824(93)90044-8","article-title":"Receptor binding of norgestimate \u2014 a new orally active synthetic progestational compound","volume":"47","author":"Juchem","year":"1993","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2006.04.005_bib2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1023\/A:1020072325818","article-title":"Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception","volume":"3","author":"Stanczyk","year":"2002","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.contraception.2006.04.005_bib3","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/0002-9378(78)90294-6","article-title":"An in vivo system in man for quantification of estrogenicity: II. Pharmacologic changes in binding capacity of corticosteroid-binding globulin induced by conjugated estrogens, mestranol, and ethinyl estradiol","volume":"130","author":"Moore","year":"1978","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2006.04.005_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0010-7824(02)00436-5","article-title":"Effect of four different oral contraceptives on various sex hormones and serum binding globulins","volume":"67","author":"Wiegratz","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2006.04.005_bib5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0010-7824(99)00093-1","article-title":"Effect of low-dose oral contraceptives on androgenic markers and acne","volume":"60","author":"Thorneycroft","year":"1999","journal-title":"Contraception"},{"issue":"Suppl 2","key":"10.1016\/j.contraception.2006.04.005_bib6","first-page":"92","article-title":"Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives","volume":"40","author":"Coenen","year":"1995","journal-title":"Int J Fertil"},{"key":"10.1016\/j.contraception.2006.04.005_bib7","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000182537","article-title":"Serum concentrations of ethinylestradiol, 3-keto-desogestrel, SHBG, CBG, and gonadotropins during treatment with a biphasic oral contraceptive containing desogestrel","volume":"38","author":"Jung-Hoffmann","year":"1992","journal-title":"Horm Res"},{"key":"10.1016\/j.contraception.2006.04.005_bib8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0010-7824(90)90034-S","article-title":"Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosterone","volume":"41","author":"Van der Vange","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2006.04.005_bib9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0010-7824(75)90088-8","article-title":"Radioimmunoassay of serum d-norgestrel in women following oral and intravaginal administration","volume":"12","author":"Stanczyk","year":"1975","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2006.04.005_bib10","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/S0002-9378(11)90772-8","article-title":"Single and multiple dose pharmacokinetics of a low dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis","volume":"168","author":"Price","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2006.04.005_bib11","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/j.ajog.2005.02.067","article-title":"Effect of oral versus transdermal steroidal contraceptives on androgenic markers","volume":"192","author":"White","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2006.04.005_bib12","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0010-7824(95)00098-U","article-title":"Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins","volume":"51","author":"Wiegratz","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2006.04.005_bib13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0015-0282(16)47956-2","article-title":"Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel","volume":"42","author":"Hammond","year":"1984","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2006.04.005_bib14","first-page":"43","article-title":"Sex hormone binding globulin, cortisol binding globulin, thyroxine binding globulin, ceruloplasmin: changes in treatment with two oral contraceptives low in oestrogen","volume":"18","author":"Sobbrio","year":"1991","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1016\/j.contraception.2006.04.005_bib15","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1210\/jcem-65-4-689","article-title":"Reduced clearance rate of thyroxine-binding globulin (TBG) with increased sialylation: a mechanism for estrogen-induced elevation of serum TBG concentration","volume":"65","author":"Ain","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2006.04.005_bib16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.contraception.2006.04.005_bib17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1538-7836.2005.01690.x","article-title":"Treatment with combined oral contraceptives induces a rise in serum C-reactive protein in the absence of a general inflammatory response","volume":"4","author":"Van Rooijen","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"Suppl 2","key":"10.1016\/j.contraception.2006.04.005_bib18","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0015-0282(01)03261-7","article-title":"Pharmacokinetic overview of Ortho Evra\u2122\/Evra\u2122","volume":"77","author":"Abrams","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2006.04.005_bib19","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.contraception.2005.03.005","article-title":"Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive","volume":"72","author":"Van den Heuvel","year":"2005","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782406002241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782406002241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T07:48:34Z","timestamp":1555746514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782406002241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0010782406002241"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2006.04.005","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}